Pentamethinium salts with an expanded quinoxaline unit and its use in anticancer therapy

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60461373%3A22330%2F15%3A43900603" target="_blank" >RIV/60461373:22330/15:43900603 - isvavai.cz</a>
Alternative codes found
RIV/60461373:22340/15:43900603
Result on the web
<a href="http://worldwide.espacenet.com/maximizedOriginalDocument?NR=2927230A1" target="_blank" >http://worldwide.espacenet.com/maximizedOriginalDocument?NR=2927230A1</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Pentamethinium salts with an expanded quinoxaline unit and its use in anticancer therapy
Original language description
Pentamethinium salts with an expanded quinoxaline unit and its use in anticancer therapy Popis: Pentamethinium salts with an expanded quinoxaline unit and its use in anticancer therapy A pentamethinium salt with an incorpoarted expanded quinoxaline unitwhich can be used as an agent with a cytostatic effect towards cancer lines and for the suppression of cancer growth.
Czech name
—
Czech description
—

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Patent/design ID
EP2927230A1
Publisher
EPO_1 -
Publisher name
European Patent Office
Place of publication
Munich, The Hague, Berlin, Vienna, Brussels
Publication country
—
Date of acceptance
Oct 7, 2015
Owner name
Vysoká škola chemicko-technologická v Praze, Praha 6- Dejvice, CZ; Ústav molekulární genetiky AV ČR, v. v. i., Praha 4, CZ; 1. LF University Karlovy, Praha 2, CZ
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence

Similar results(10)